Characterization of glycosaminoglycans in regenerating canine liver

Journal of Hepatology

Volumn 26, Issue 5, 1997, Pages 1135-1140

  Toyoki, Yoshikazu ^a   Yoshihara, Syuichi ^a   Sasaki, Mutsuo ^a   Konn, Mitsuru ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Anti proliferating cell nuclear antigen antibody; Glycosaminoglycan; Liver regeneration

Indexed keywords

GLYCOSAMINOGLYCAN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; DOG; EXTRACELLULAR MATRIX; LIVER REGENERATION; LIVER RESECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030948763     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80123-7     Document Type: Article

References (31)

1. Cohen S, Carpenter G. Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci USA. 72:1975;1317-1321.
2. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 122:1984;1450-1459.
3. Nakamura T, Arakaki R, Ichihara A. Interleukin-1 β is a potent growth inhibitor of adult rat hepatocytes in primary culture. Exp Cell Res. 179:1988;488-497.
4. Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun. 133:1985;1042-1050.
5. Roden L. Structure and metabolism of connective tissue proteoglycans. Lennerz WJ. The Biochemistry of Glycoproteins and Proteoglycans. 1980;267-371 Plenum Press, New York.
6. Poole AR. Proteoglycans in health and disease: structures and functions. Biochem J. 236:1986;1-14.
7. Wight TN, Heinegard DK, Hascall VC. Proteoglycans: structure and function. Hay ED. 2nd Edn Cell Biology of Extracellular Matrix. 1991;45-78 Plenum Press, New York.
8. Ohnishi T, Ohshima E, Ohtsuka M. Effect of liver cell coat acid mucopolysaccharide on the appearance of density-dependent inhibition in hepatoma cell growth. Exp Cell Res. 93:1975;136-142.
9. Geerts A, Geuze HJ, Slot J-W, Voss B, Schuppan D, Schellinck P, Wisse E. Immunogold localization of procollagen III, fibronectin and heparan sulfate proteoglycan on ultrathin frozen sections of the normal rat liver. Histochemistry. 84:1986;355-362.
10. Kawakami H, Terayama H. Liver plasma membranes and proteoglycan prepared therefrom inhibit the growth of hepatoma cells in vitro. Biochim Biophys Acta. 646:1981;161-168.
11. Koide N, Shinji T, Tanabe T, Asano K, Kawaguchi M, Sakaguchi K, Koide Y, Mori M, Tsu T. Continued high albumin production by multicellular spheroids of adult rat hepatocytes formed in the presence of liver-derived proteoglycans. Biochem Biophys Res Commun. 161:1989;385-391.
12. Spray DC, Fujita M, Saez JC, Choi H, Watanabe T, Hertzberg E, Rosenberg LC, Seid LM. Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures. J Cell Biol. 105:1987;541-551.
13. Gressner AM. Hepatic proteoglycans: a brief survey of their pathobiochemical implications. Hepato-Gastroenterology. 30:1983;225-229.
14. Traub O, Drauge PM, Willecke K. Degradation and resynthesis of gap function protein in plasma membranes of regenerating liver after partial hepatectomy or cholestasis. Proc Natl Acad Sci USA. 80:1983;755-759.
15. Arenson DM, Bissell DM. Glycosaminoglycan, proteoglycan, and hepatic fibrosis. Gastroenterology. 92:1987;536-540.
16. Roskams T, Moshage H, Vos RD, Guido D, Yap P, Desmet V. Heparin sulfate proteoglycan expression in normal human liver. Hepatology. 21:1995;950-958.
17. Edward M, Long WF, Watson HK, Williamson FB. Sulfated glycosaminoglycans in regenerating rat liver. Biochem J. 188:1980;769-773.
18. Gressner AM, Cadenbach JE, Greiling H. Synhesis in vitro of glycosaminoglycans in regenerating rat liver. J Clin Chem Clin Biochem. 19:1981;465-469.
19. Otsu K, Kato S, Ohtake K, Akamatsu N. Alteration of rat liver proteoglycans during regeneration. Arch Biochem Biophys. 294:1992;544-549.
20. Takagaki K, Nakamura T, Majima M, Endo M. Isolation and characterization of a chondroitin sulfate-degrading endo-glucuronidase from rabbit liver. J Biol Chem. 263:1988;7000-7006.
21. Nakamura T, Majima M, Kubo K, Takagaki K, Tamura S, Endo M. Hyaluronidase assay using fluorogenic hyaluronate as a substrate. Anal Biochem. 191:1990;21-24.
22. Takagaki K, Kojima K, Majima M, Nakamura T, Kato I, Endo M. Ion-spray mass spectrometric analysis of glycosaminoglycan oligosaccharides. Glycoconjugate J. 9:1992;174-179.
23. Hsu S, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem. 29:1981;577-580.
24. Julio EC, Ariana C. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA. 82:1985;3262-3266.
25. Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem. 4:1962;330-334.
26. Yokoyama M, Tanaka H, Yoshihara S, Endo M. A method for the identification of sulfated glycopeptideby two-dimensional electrophoresis on cellulose acetate membrane. J Biochem Biophys Meth. 12:1986;239-246.
27. Kon A, Takagaki K, Kawasaki H, Nakamura T, Endo M. Application of 2-aminopyridine fluorescence labeling to glycosaminoglycans. J Biochem. 110:1991;132-135.
28. Masumoto A, Yamamoto N. Sequestrtion of a hepatocyte growth factor in extracellular matrix in normal adult rat liver. Biochem Biophys Res Commun. 174:1991;90-95.
29. Presta M, Statuto M, Rusnati M, Dell'Era P, Ragnotti G. Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. Biochem Biophys Res Commun. 164:1989;1182-1189.
30. Gallagher JT, Lyon M, Steward WP. Structure and function of heparan sulfate proteoglycans. Biochem J. 236:1986;313-325.
31. Fedarko NS, Conrad HE. A unique heparan sulfate in the nuclei of hepatocyte: structural changes with the growth state of the cells. J Cell Biol. 102:1986;587-599.